Is Avanos Medical, Inc. (AVNS) a Buy, Sell, or Hold?
NYSE : AVNS
Avanos Medical, Inc.
$24.99 USD
$0.01 (0.04%)
- Volume
- 432.16K
- Average Volume
- 1.09M
- Market Capitalization
- $1.17B
- P/E Ratio
- -16.65
- Dividend Yield
- 0.00%
- Price Target
- $23.00
- Year High
- $25.49
- Year Low
- $9.30
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.48
Company Overview
NYSE
David C. Pacitti
Medical - Devices
Healthcare
AVNS
2287
US
USD
Liquidity Metrics
0.18
2.48
1.40
0.50
0.00
Sales & Valuation
$701.2M
1.64
1.48
156.10
0.16
Profitability
-$1.46
-$67.9M
-9.69%
-9.54%
-8.91%
-6.61%
P/E Metrics
-16.65
-0.39
-0.39
Analyst Price Target & Rating
$23.00
$26.00
$20.00
0/5
8 Analysts
8.65%
Financial Health Scores
2.30
4/9
$193.8M
$1.05B
$268M
-$61.1M
Key Metrics (TTM)
$1.24B
1.74
-57.57
2.48
-8.91%
-6.03%
-5.99%
0.64%
141 days
Company Executives
| Name | Title |
|---|---|
| Sigfrido Delgado | Senior Vice President of Operations |
| David C. Pacitti | Chief Executive Officer & Director |
| Jason Pickett | Vice President of Corporate Finance & Treasurer |
| John Joseph Hurley | Principal Accounting Officer & Controller |
| John S. Fischer | Vice President, Head of Legal & Secretary |
| Jonathan Turner | Vice President and Chief Ethics & Compliance Officer |
| Scott Michael Galovan | Chief Financial Officer & Senior Vice President |
| Jamie Handler | Vice President of Global Marketing |
| Katrine Kubis | Vice President of Corporate Communications & Community Relations |
| Siobhan Smyth | Vice President & Chief Information Officer |
Poll Results
No votes yet today — be the first to share your view!
About Avanos Medical, Inc. (NYSE:AVNS) Stock
Avanos Medical, Inc. is a pioneering medical technology enterprise dedicated to furnishing device solutions across a broad international footprint, encompassing North America, Europe, the Middle East, Africa, the Asia Pacific region, and Latin America. Its comprehensive product array targets two primary areas: chronic care and non-opioid pain management. Within chronic care, the company provides digestive health offerings such as Mic-Key enteral feeding tubes, Corpak patient feeding systems, and NeoMed solutions tailored for neonatal and pediatric patients. Its respiratory health segment includes closed airway suction systems and other airway management devices, marketed under prominent brands like Ballard, Microcuff, and Endoclear. For non-opioid pain relief, Avanos offers acute pain solu ... tions, including On-Q and ambIT surgical pain pumps, along with Game Ready cold and compression therapy systems. It also features interventional pain solutions, providing minimally invasive therapies like Coolief for long-term pain alleviation. The company facilitates product access by selling directly to hospitals, various healthcare providers, and end-user facilities, in addition to utilizing third-party wholesale distributors. Originally incorporated in 2014 and known as Halyard Health, Inc., the company officially adopted the name Avanos Medical, Inc. in June 2018 and maintains its headquarters in Alpharetta, Georgia.
Sterlington Advises Avanos Medical Management Team on $1.27 Billion Acquisition
2026-07-29 15:14:00
NEW YORK--(BUSINESS WIRE)--Sterlington advises Avanos Medical management team on $1.27 billion acquisition.
Avanos Medical, Inc. Stockholders Approve Acquisition by American Industrial Partners
2026-07-22 16:05:00
ALPHARETTA, Ga., July 22, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos" or the "Company"), a leading medical technology company, today announced that its stockholders have voted to approve the pending acquisition of Avanos by affiliates of investment funds advised by American Industrial Partners ("AIP") at a special meeting of stockholders (the "Special Meeting") held earlier today.
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600
2026-07-20 17:42:00
NEW YORK, July 20, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600
2026-07-02 10:00:00
ALPHARETTA, Ga. and NEW YORK, July 2, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) ("Avanos") and American Industrial Partners ("AIP") jointly announced the receipt of all required regulatory approvals to complete the pending acquisition of Avanos by affiliates of investment funds advised by AIP (the "Merger").
Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders?
2026-06-25 14:00:00
Are CRBG, EQH, AVNS Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, June 25, 2026
2026-06-24 15:00:00
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of [url="]Kahn Swick and Foti[/url], LLC (âKSFâ) are investigating the propos
2026-06-24 14:54:00
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Avanos Medical, Inc. (NYSE: AVNS) to affiliates of American Industrial Partners. Under the terms of the proposed transaction, shareholders of Avanos will receive $25.00 in cash for each share of Avanos that they own. KSF is seeking to determine whether this consideration and the process that led to i.
Reasons to Retain Avanos Medical Stock in Your Portfolio for Now
2026-06-24 10:50:41
AVNS' SNS momentum, Nexus Medical integration and AIP deal support growth, but tariff costs, margin pressure and PM&R weakness remain headwinds.
Frequently Asked Questions
-
What is the current Avanos Medical, Inc. (AVNS) stock price?
-
Avanos Medical, Inc.(NYSE:AVNS) stock price is $24.99 in the last trading session. During the trading session, AVNS stock reached the peak price of $25.49 while $9.303 was the lowest point it dropped to. The percentage change in AVNS stock occurred in the recent session was 0.04% while the dollar amount for the price change in AVNS stock was $0.01.
-
AVNS's industry and sector of operation?
-
The NYSE listed AVNS is part of Medical - Devices industry that operates in the broader Healthcare sector.
-
Who are the executives of AVNS?
-
Sigfrido Delgado | Senior Vice President of Operations
David C. Pacitti | Chief Executive Officer & Director
Jason Pickett | Vice President of Corporate Finance & Treasurer
John Joseph Hurley | Principal Accounting Officer & Controller
John S. Fischer | Vice President, Head of Legal & Secretary -
How many employees does AVNS have?
-
Number of AVNS employees currently stands at 2287. AVNS operates from 5405 Windward Parkway, Alpharetta, GA 30004, US.
-
Link for AVNS official website?
-
Official Website of AVNS is: https://avanos.com
-
How do I contact AVNS?
-
AVNS could be contacted at phone #844 428 2667 and can also be accessed through its website. AVNS operates from 5405 Windward Parkway, Alpharetta, GA 30004, US.
-
How many shares of AVNS are traded daily?
-
The average number of AVNS shares traded daily for last 3 months was 1.09M.
-
What is the market cap of AVNS currently?
-
The market value of AVNS currently stands at $1.17B with its latest stock price at $24.99